TrialCancer research and treatment2018

Phase II Study of Induction Chemotherapy with Docetaxel, Capecitabine, and Cisplatin Plus Bevacizumab for Initially Unresectable Gastric Cancer with Invasion of Adjacent Organs or Paraaortic Lymph Node Metastasis.

Jwa Hoon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.